company background image
DXCM

DexCom NasdaqGS:DXCM Stock Report

Last Price

US$87.50

Market Cap

US$33.9b

7D

-9.2%

1Y

8.5%

Updated

23 Sep, 2023

Data

Company Financials +

DXCM Stock Overview

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.

DXCM fundamental analysis
Snowflake Score
Valuation2/6
Future Growth5/6
Past Performance5/6
Financial Health5/6
Dividends0/6

DexCom, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for DexCom
Historical stock prices
Current Share PriceUS$87.50
52 Week HighUS$139.55
52 Week LowUS$78.94
Beta1.12
1 Month Change-13.35%
3 Month Change-30.97%
1 Year Change8.48%
3 Year Change-13.01%
5 Year Change144.69%
Change since IPO2,881.26%

Recent News & Updates

DexCom (NASDAQ:DXCM) Could Easily Take On More Debt

Sep 13
DexCom (NASDAQ:DXCM) Could Easily Take On More Debt

Calculating The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)

Aug 29
Calculating The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)

Should You Think About Buying DexCom, Inc. (NASDAQ:DXCM) Now?

Aug 14
Should You Think About Buying DexCom, Inc. (NASDAQ:DXCM) Now?

Recent updates

DexCom (NASDAQ:DXCM) Could Easily Take On More Debt

Sep 13
DexCom (NASDAQ:DXCM) Could Easily Take On More Debt

Calculating The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)

Aug 29
Calculating The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)

Should You Think About Buying DexCom, Inc. (NASDAQ:DXCM) Now?

Aug 14
Should You Think About Buying DexCom, Inc. (NASDAQ:DXCM) Now?

DexCom (NASDAQ:DXCM) Has A Rock Solid Balance Sheet

Jun 05
DexCom (NASDAQ:DXCM) Has A Rock Solid Balance Sheet

There's Been No Shortage Of Growth Recently For DexCom's (NASDAQ:DXCM) Returns On Capital

May 16
There's Been No Shortage Of Growth Recently For DexCom's (NASDAQ:DXCM) Returns On Capital

Do DexCom's (NASDAQ:DXCM) Earnings Warrant Your Attention?

Mar 21
Do DexCom's (NASDAQ:DXCM) Earnings Warrant Your Attention?

These 4 Measures Indicate That DexCom (NASDAQ:DXCM) Is Using Debt Safely

Mar 03
These 4 Measures Indicate That DexCom (NASDAQ:DXCM) Is Using Debt Safely

DexCom (NASDAQ:DXCM) Is Doing The Right Things To Multiply Its Share Price

Feb 13
DexCom (NASDAQ:DXCM) Is Doing The Right Things To Multiply Its Share Price

DexCom (NASDAQ:DXCM) Seems To Use Debt Quite Sensibly

Nov 25
DexCom (NASDAQ:DXCM) Seems To Use Debt Quite Sensibly

Returns Are Gaining Momentum At DexCom (NASDAQ:DXCM)

Oct 21
Returns Are Gaining Momentum At DexCom (NASDAQ:DXCM)

Dexcom launches G7 glucose monitoring system in parts of Europe, Asia

Oct 04

What Is DexCom, Inc.'s (NASDAQ:DXCM) Share Price Doing?

Sep 24
What Is DexCom, Inc.'s (NASDAQ:DXCM) Share Price Doing?

DexCom: A High-Priced Medical Devices Company Remains Stuck In A Downtrend

Sep 21

DexCom promotes technology chief Leach to COO

Aug 31

DexCom (NASDAQ:DXCM) Has A Pretty Healthy Balance Sheet

Aug 01
DexCom (NASDAQ:DXCM) Has A Pretty Healthy Balance Sheet

DexCom stock down ~7% after hours as Q2 results miss expectations

Jul 28

Estimating The Intrinsic Value Of DexCom, Inc. (NASDAQ:DXCM)

Jul 13
Estimating The Intrinsic Value Of DexCom, Inc. (NASDAQ:DXCM)

DexCom: I Wouldn't Buy The Dip

Jul 07

Is It Time To Consider Buying DexCom, Inc. (NASDAQ:DXCM)?

Jun 24
Is It Time To Consider Buying DexCom, Inc. (NASDAQ:DXCM)?

We Like These Underlying Return On Capital Trends At DexCom (NASDAQ:DXCM)

Jun 03
We Like These Underlying Return On Capital Trends At DexCom (NASDAQ:DXCM)

DexCom: Q1'22 Earnings Strong Enough To Maintain Valuation But Not To Increase It

May 01

DexCom (NASDAQ:DXCM) Seems To Use Debt Quite Sensibly

Apr 12
DexCom (NASDAQ:DXCM) Seems To Use Debt Quite Sensibly

DexCom, Inc. (NASDAQ:DXCM) Shares Could Be 21% Below Their Intrinsic Value Estimate

Mar 28
DexCom, Inc. (NASDAQ:DXCM) Shares Could Be 21% Below Their Intrinsic Value Estimate

Returns Are Gaining Momentum At DexCom (NASDAQ:DXCM)

Feb 03
Returns Are Gaining Momentum At DexCom (NASDAQ:DXCM)

DexCom: Buy The Dip For Robust Product Portfolio And Healthy Financials

Feb 01

Is Now The Time To Put DexCom (NASDAQ:DXCM) On Your Watchlist?

Dec 30
Is Now The Time To Put DexCom (NASDAQ:DXCM) On Your Watchlist?

DexCom: Fast Growing Medical Device Company For Diabetes Care

Dec 21

Is DexCom (NASDAQ:DXCM) Using Too Much Debt?

Dec 13
Is DexCom (NASDAQ:DXCM) Using Too Much Debt?

Returns At DexCom (NASDAQ:DXCM) Are On The Way Up

Nov 04
Returns At DexCom (NASDAQ:DXCM) Are On The Way Up

DexCom's Price: With The New G7 System And Partnerships, It May Spike Up

Oct 08

Here's Why We Think DexCom (NASDAQ:DXCM) Is Well Worth Watching

Sep 30
Here's Why We Think DexCom (NASDAQ:DXCM) Is Well Worth Watching

Shareholder Returns

DXCMUS Medical EquipmentUS Market
7D-9.2%-3.1%-3.1%
1Y8.5%6.1%15.1%

Return vs Industry: DXCM exceeded the US Medical Equipment industry which returned 6.1% over the past year.

Return vs Market: DXCM underperformed the US Market which returned 15.1% over the past year.

Price Volatility

Is DXCM's price volatile compared to industry and market?
DXCM volatility
DXCM Average Weekly Movement5.5%
Medical Equipment Industry Average Movement7.1%
Market Average Movement5.5%
10% most volatile stocks in US Market14.2%
10% least volatile stocks in US Market2.5%

Stable Share Price: DXCM is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: DXCM's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19997,550Kevin Sayerhttps://www.dexcom.com

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions.

DexCom, Inc. Fundamentals Summary

How do DexCom's earnings and revenue compare to its market cap?
DXCM fundamental statistics
Market CapUS$33.94b
Earnings (TTM)US$357.50m
Revenue (TTM)US$3.20b

94.9x

P/E Ratio

10.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
DXCM income statement (TTM)
RevenueUS$3.20b
Cost of RevenueUS$1.15b
Gross ProfitUS$2.04b
Other ExpensesUS$1.69b
EarningsUS$357.50m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.92
Gross Margin63.94%
Net Profit Margin11.18%
Debt/Equity Ratio152.6%

How did DXCM perform over the long term?

See historical performance and comparison